... San Antonio, Texas. There was a “dose dependent increase in nausea and vomiting,” as can be expected with this molecule, Sharon Barr, executive ...
News
- AstraZeneca Says Obesity Pill Well-Tolerated, Highly Competitive - Bloomberg News
- bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) (“bioAffinity” or the “Company”), a biotechnology company ...
- BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast ...
BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13 · In This Article:.
- Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell ...
The collaboration enables clients to work with Scorpius' program management team while preparing to transfer research cell banks to their San Antonio ...
- Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential ...
San Antonio Breast Cancer Symposium, December 10-13, 2024, in San ... Biotechnology: Pharmaceutical Preparations. Health Care. Electric ...